busulfan has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We performed a retrospective analysis of the incidence, risk factors, and clinical outcome of hepatic veno-occlusive disease (VOD) in 50 children prepared for bone marrow transplantation with busulfan (16 mg/kg) and cyclophosphamide (200 mg/kg)." | 7.68 | Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome. ( Kohn, D; Lenarsky, C; Ozkaynak, MF; Parkman, R; Sender, L; Weinberg, K, 1991) |
| "We performed a retrospective analysis of the incidence, risk factors, and clinical outcome of hepatic veno-occlusive disease (VOD) in 50 children prepared for bone marrow transplantation with busulfan (16 mg/kg) and cyclophosphamide (200 mg/kg)." | 3.68 | Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome. ( Kohn, D; Lenarsky, C; Ozkaynak, MF; Parkman, R; Sender, L; Weinberg, K, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gutti, TL | 1 |
| Knibbe, JS | 1 |
| Makarov, E | 1 |
| Zhang, J | 1 |
| Yannam, GR | 1 |
| Gorantla, S | 1 |
| Sun, Y | 1 |
| Mercer, DF | 1 |
| Suemizu, H | 1 |
| Wisecarver, JL | 1 |
| Osna, NA | 1 |
| Bronich, TK | 1 |
| Poluektova, LY | 1 |
| Tomás, JF | 1 |
| Rodriguez-Iñigo, E | 1 |
| Bartolomé, J | 1 |
| Alegre, A | 1 |
| Fernández-Rañada, JM | 1 |
| Carreño, V | 1 |
| Ozkaynak, MF | 1 |
| Weinberg, K | 1 |
| Kohn, D | 1 |
| Sender, L | 1 |
| Parkman, R | 1 |
| Lenarsky, C | 1 |
3 other studies available for busulfan and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
Human hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned uPA-NOG mice.
Topics: Animals; Antineoplastic Agents, Alkylating; Busulfan; Coinfection; Disease Models, Animal; Hematopoi | 2014 |
Transplantation of allogeneic CD34-selected peripheral stem cells does not prevent transmission of hepatitis C virus from an infected donor.
Topics: Adult; Antigens, CD34; Busulfan; Cyclophosphamide; Hematopoietic Stem Cell Transplantation; Hepacivi | 1999 |
Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; | 1991 |